Pages that link to "Q37340689"
Jump to navigation
Jump to search
The following pages link to Transplantation of human islets without immunosuppression (Q37340689):
Displaying 50 items.
- Survival of encapsulated islets: More than a membrane story (Q26751467) (← links)
- Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement (Q26769878) (← links)
- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (Q26772152) (← links)
- THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away (Q26827749) (← links)
- Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges (Q27010290) (← links)
- Acute Ischemia Induced by High Density Culture Increases Cytokine Expression and Diminishes the Function and Viability of Highly Purified Human Islets of Langerhans (Q30491064) (← links)
- Impact of Pancreatic Rat Islet Density on Cell Survival during Hypoxia (Q33467085) (← links)
- Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression (Q34043187) (← links)
- Treatment of diabetes with encapsulated pig islets: an update on current developments (Q34044048) (← links)
- Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release (Q34446322) (← links)
- Transplantation of bovine adrenocortical cells encapsulated in alginate (Q35134522) (← links)
- Bioengineered stem cells as an alternative for islet cell transplantation (Q35210721) (← links)
- Engineering biomimetic materials for islet transplantation (Q35661081) (← links)
- Re-engineering islet cell transplantation. (Q35748517) (← links)
- Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device (Q36217538) (← links)
- Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices (Q36236680) (← links)
- Cell therapy for type 1 diabetes (Q37671887) (← links)
- Concise review: pluripotent stem cell-based regenerative applications for failing β-cell function (Q38197390) (← links)
- Islet cell xenotransplantation: a serious look toward the clinic (Q38210098) (← links)
- Islet transplantation for Type 1 diabetes: where are we now? (Q38278288) (← links)
- Advances in cell encapsulation technology and its application in drug delivery (Q38308868) (← links)
- Anti-diabetic and neuroprotective effects of pancreatic islet transplantation into the central nervous system (Q38364557) (← links)
- Xenotransplantation of islet cells: what can the non-human primate model bring for the evaluation of efficacy and safety? (Q38443042) (← links)
- Avoiding immunological rejection in regenerative medicine. (Q38453650) (← links)
- New directions for the treatment of adrenal insufficiency (Q38497224) (← links)
- Transplantable bioartificial pancreas devices: current status and future prospects (Q38528327) (← links)
- Development of an encapsulated stem cell-based therapy for diabetes. (Q38544140) (← links)
- Xenotransplantation of Cells, Tissues, Organs and the German Research Foundation Transregio Collaborative Research Centre 127. (Q38573603) (← links)
- Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices (Q38651610) (← links)
- Islet cell transplant: Update on current clinical trials (Q38689971) (← links)
- Cell Therapy for Type 1 Diabetes: Current and Future Strategies. (Q38692115) (← links)
- An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport (Q38692804) (← links)
- First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotra (Q38751293) (← links)
- Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future. (Q38762314) (← links)
- Long-term function and optimization of mouse and human islet transplantation in the subcutaneous device-less site (Q38797868) (← links)
- Advances in β cell replacement and regeneration strategies for treating diabetes (Q38970248) (← links)
- Advances in islet encapsulation technologies (Q39051114) (← links)
- Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus (Q39069908) (← links)
- Development and Validation of Noninvasive Magnetic Resonance Relaxometry for the In Vivo Assessment of Tissue-Engineered Graft Oxygenation (Q39272722) (← links)
- Encapsulated Islet Transplantation: Where Do We Stand? (Q39386173) (← links)
- Islet cell transplantation from Göttingen minipigs to cynomolgus monkeys: analysis of virus safety (Q40605741) (← links)
- Xenogeneic cell therapeutics: Treatment of type 1 diabetes using porcine pancreatic islets and islet cells (Q41000726) (← links)
- Microfabrication for Drug Delivery (Q41006286) (← links)
- The Efficacy of a Prevascularized, Retrievable Poly(D,L,-lactide-co-ε-caprolactone) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets. (Q46118102) (← links)
- Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells". (Q47096061) (← links)
- Layered PEGDA hydrogel for islet of Langerhans encapsulation and improvement of vascularization (Q47107020) (← links)
- Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas β Air to Patients with Type 1 Diabetes Mellitus (Q47210419) (← links)
- Historical Perspectives and Current Challenges in Cell Microencapsulation (Q47385371) (← links)
- Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes (Q47403119) (← links)
- The Journey of Islet Cell Transplantation and Future Development. (Q47696722) (← links)